Also trades as: AGY.L (LSE) · $vol 0M
AGYTF Earnings
Allergy Therapeutics plc
1W: +0.0%
1M: +0.0%
3M: +7.1%
YTD: +36.4%
1Y: +76.5%
3Y: -38.3%
5Y: -31.8%
$0.15
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Last Earnings
2026-03-31
EPS
£-0.01 (US$-0.01)
▲ Beat +0.0%
Revenue
£49M ($65M)
▼ Miss -0.1%
Estimate vs Actual
Earnings Surprise History
1/20
EPS Beats
3/20
Revenue Beats
5%
EPS Beat Rate
15%
Rev Beat Rate
Wall Street Forward Estimates
Quarterly
Annual
Estimate Revisions
Recent Revisions
| Date | Period | Fiscal Date | EPS Old | EPS New | Change | Rev Old | Rev New |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | annual | 2027-06-30 | £0.01 | £0.01 | — | £342,024,360 | £342,929,460 |
| 2026-10-01 | annual | 2027-06-30 | £0.01 | £0.01 | — | £342,748,440 | £342,024,360 |
| 2026-09-30 | annual | 2027-06-30 | £0.01 | £0.01 | — | £342,386,400 | £342,748,440 |
| 2026-09-29 | annual | 2027-06-30 | £0.01 | £0.01 | — | £341,610,600 | £342,386,400 |
| 2026-09-25 | annual | 2027-06-30 | £0.01 | £0.01 | — | £342,386,400 | £341,610,600 |
| 2026-09-24 | annual | 2027-06-30 | £0.01 | £0.01 | — | £344,946,540 | £342,386,400 |
| 2026-09-23 | annual | 2027-06-30 | £0.01 | £0.01 | — | £345,593,040 | £344,946,540 |
| 2026-09-22 | annual | 2027-06-30 | £0.01 | £0.01 | — | £346,342,980 | £345,593,040 |
| 2026-09-21 | annual | 2027-06-30 | £0.01 | £0.01 | — | £348,385,920 | £346,342,980 |
| 2026-09-17 | annual | 2027-06-30 | £0.01 | £0.01 | — | £349,006,560 | £348,385,920 |
| 2026-09-16 | annual | 2027-06-30 | £0.01 | £0.01 | — | £349,627,200 | £349,006,560 |
| 2026-09-15 | annual | 2027-06-30 | £0.01 | £0.01 | — | £349,265,160 | £349,627,200 |
| 2026-09-14 | annual | 2027-06-30 | £0.01 | £0.01 | — | £350,299,560 | £349,265,160 |
| 2026-09-11 | annual | 2027-06-30 | £0.01 | £0.01 | — | £349,963,380 | £350,299,560 |
| 2026-09-10 | annual | 2027-06-30 | £0.01 | £0.01 | — | £350,170,260 | £349,963,380 |
Earnings Call Transcripts
No transcripts available.